This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Other leukaemias of specified cell type
CD2_OTHER_LEUKAEMIA_SPECIFIED
leukemia: A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
89 |
4. Check minimum number of eventsNone |
89 |
5. Include endpointsNone |
89 |
6. Filter based on genotype QC (FinnGen only) |
89 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF8
- Parent code in ICD-10
- C81-C96
- Name in latin
- Aliae leuc(h)aemiae typo cellulari specificato
Similar endpoints
↥List of similar endpoints to
Other leukaemias of specified cell type
based on the number of shared cases.
Similar with more cases:
- Other leukaemias of specified cell type
- Primary_lymphoid and hematopoietic malignant neoplasms
- Primary_lymphoid and hematopoietic malignant neoplasms
- Malignant neoplasm
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 89 | 48 | 41 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | 54.77 | 52.22 | 57.76 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 80
- Matched controls
- 800
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
127
Kela drug reimbursment
Transplant complication
130.3
31.5
32
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
57.8
31.2
36
11
C94.0
ICD-10 Finland
Acute erythroid leukaemia
+∞
25.3
23
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
23.1
19.9
29
19
L04AA06
ATC
mycophenolic acid; systemic
93.2
19.8
21
*
C94.7
ICD-10 Finland
Other specified leukaemias
+∞
19.6
18
*
XW000
NOMESCO Finland
Bone marrow biopsy
23.2
18.7
27
17
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
17.3
17.3
28
24
L04AD01
ATC
ciclosporin; systemic
30.9
16.1
21
9
L04AA01
ATC
[U] ciclosporin; systemic
34.9
15.1
19
7
ZX120
NOMESCO Finland
Intravenous
12.4
14.9
28
33
WW500
NOMESCO Finland
Blood transfusion
27.1
14.1
19
9
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
13.9
13
*
Z94.0
ICD-10 Finland
Kidney transplant status
55.7
12.3
14
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
76.4
12.0
13
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
21.8
11.3
16
9
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
125.7
10.7
11
*
TK800
NOMESCO Finland
Hemodialysis
27.8
10.7
14
6
ZX108
NOMESCO Finland
Inhalation
+∞
10.6
10
*
L03AA02
ATC
filgrastim; parenteral
23.8
10.2
14
7
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.8
10.1
54
240
A05AA02
ATC
ursodeoxycholic acid; oral
112.7
9.6
10
*
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
112.7
9.6
10
*
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
112.7
9.6
10
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
7.6
9.5
23
40
Z3231
NOMESCO Finland
Registered nurse
4.7
9.5
42
152
H02AB09
ATC
hydrocortisone; systemic
18.5
9.4
14
9
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
21.8
9.3
13
7
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
5.9
9.0
27
63
R4110
NOMESCO Finland
Physiotherapy
4.6
8.9
38
131
Z49.1
ICD-10 Finland
Extracorporeal dialysis
31.4
8.7
11
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.5
8.7
28
71
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
100.0
8.6
9
*
L01BB02
ATC
mercaptopurine; oral
100.0
8.6
9
*
Z3226
NOMESCO Finland
Physiotherapist
4.8
8.5
33
102
C94.2
ICD-10 Finland
Acute megakaryoblastic leukaemia
+∞
8.5
8
*
C94.4
ICD-10 Finland
Acute panmyelosis with myelofibrosis
+∞
8.5
8
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
7.1
8.4
21
38
R50.9
ICD-10 Finland
Fever, unspecified
5.3
8.2
27
70
H02AB04
ATC
methylprednisolone; systemic
5.3
8.2
27
70
C03CA01
ATC
furosemide; systemic
4.3
8.2
37
133
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
50.0
7.9
9
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
15.4
7.7
12
9
TGC00
NOMESCO Finland
Bronchial lavation
15.4
7.7
12
9
Z2221
NOMESCO Finland
Medical doctor
4.1
7.6
37
138
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
87.8
7.5
8
*
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
+∞
7.4
7
*
6BA02
NOMESCO Finland
NA
+∞
7.4
7
*
C94.1
ICD-10 Finland
Chronic erythremia
+∞
7.4
7
*
Z2446
NOMESCO Finland
Social worker
6.9
7.3
18
32
TAB00
NOMESCO Finland
Lumbar puncture
9.7
7.2
14
17
L04AX01
ATC
azathioprine; systemic
10.8
7.1
13
14
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
43.9
6.9
8
*
N18.0
ICD-10 Finland
End-stage renal disease
43.9
6.9
8
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
10.1
6.9
13
15
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
10.1
6.9
13
15
ZXE30
NOMESCO Finland
More than five and less than seven hours
10.1
6.9
13
15
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
9.4
6.6
13
16
A11CC03
ATC
alfacalcidol; systemic
16.0
6.6
10
7
Z3229
NOMESCO Finland
Other healthcare associate professional
6.0
6.6
18
37
Z94.1
ICD-10 Finland
Heart transplant status
75.5
6.5
7
*
J01MA12
ATC
levofloxacin; systemic
4.1
6.5
28
93
KA1AE
NOMESCO Finland
Kidney ultrasound examination
20.0
6.4
9
5
ZX112
NOMESCO Finland
Subcutaneous
29.2
6.4
8
*
20700
ICD-8 Finland
Other and unspecified leukaemia, Leukaemia, acute
+∞
6.3
6
*
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
+∞
6.3
6
*
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
+∞
6.3
6
*
J02AC03
ATC
voriconazole; systemic
+∞
6.3
6
*
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
+∞
6.3
6
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
6.3
6
*
C94.5
ICD-10 Finland
Acute myelofibrosis
+∞
6.3
6
*
N18.8
ICD-10 Finland
Other chronic renal failure
14.0
6.3
10
8
J05AB01
ATC
aciclovir; systemic
3.8
6.2
29
103
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
8.4
6.2
13
18
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
7.5
6.2
14
22
A12AA04
ATC
calcium carbonate; oral
16.6
6.1
9
6
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
20
10
25.51
26.55
1.6
1.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
19
15
15.83
20.08
1.5
1.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
42
98
7.22
19.19
22.0
7.0
mmol/l
1.1
1.1
0.01
42
92
(3048929) Epstein Barr virus Ab [Presence] in Serum
22
24
11.85
19.04
1.5
1.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
31
58
7.67
17.35
6.0
4.0
e9/l
71.3
68.8
0.17
22
49
(3042111) Morphology [Interpretation] in Bone marrow Narrative
14
10
16.43
15.39
3.6
2.0
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
34
79
6.35
15.19
8.9
3.9
%
1.9
1.6
0.98
34
73
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
25
43
7.69
14.94
3.5
1.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
34
82
6.09
14.54
2.2
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
40
117
5.39
13.67
3.9
1.7
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
13
10
15.05
13.66
1.7
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
33
83
5.73
13.37
2.3
1.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
54
207
5.09
13.15
17.0
4.3
ph
7.4
7.4
—
8
34
(3012095) Magnesium [Moles/volume] in Serum or Plasma
40
126
4.95
12.32
11.3
3.9
mmol/l
0.8
0.8
0.62
40
115
(3023368) Bacteria identified in Blood by Culture
49
192
4.45
11.17
12.4
4.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
15
7
25.35
11.11
1.4
1.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
56
246
4.44
10.83
18.0
5.3
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
17
27
7.55
10.70
4.3
2.5
%
88.7
84.7
0.20
17
27
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
68
349
5.02
10.54
25.9
7.3
mmol/l
1.2
1.2
0.31
62
298
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
15
21
8.39
10.48
5.5
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
15
9
19.69
10.29
2.8
2.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
16
25
7.58
10.19
6.1
1.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
16
25
7.58
10.19
5.4
1.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
16
25
7.58
10.19
2.3
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
30
86
4.75
10.15
2.4
1.4
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
67
357
4.55
9.45
20.9
5.4
%
55.2
56.7
0.33
67
338
(21494434) Karyotype in Bone marrow
14
9
18.14
9.39
1.4
1.0
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
30
96
4.21
8.68
5.5
2.3
g/l
2.1
2.4
1.31
30
90
(3021879) Hepatitis B virus core Ab [Presence] in Serum
22
56
4.89
8.48
1.5
1.4
—
—
—
0
0
(4035726)
25
71
4.51
8.43
2.1
1.3
—
—
—
0
0
(44790047)
10
11
10.12
8.24
3.1
1.6
—
—
—
0
0
(44790048)
10
11
10.12
8.24
3.1
1.6
—
—
—
0
0
(44806118)
10
11
10.12
8.24
3.1
1.6
—
—
—
0
0
(44790049)
10
11
10.12
8.24
3.1
1.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
44
191
3.58
8.08
21.2
6.8
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
23
64
4.50
7.92
14.7
3.3
%
1.8
0.7
1.21
17
23
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
15
8.23
7.73
2.8
1.8
—
—
—
0
0
(3024471) HLA-A [Type]
7
0
+∞
7.39
1.0
0.0
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
29
101
3.78
7.33
5.8
2.4
umol/l
12.1
15.3
1.33
29
94
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
10
5
22.22
7.31
3.8
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
13
23
6.45
7.30
2.4
2.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
13
8.54
7.27
2.3
1.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
21
58
4.43
7.26
14.6
3.4
%
0.5
0.2
0.95
16
20
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
13
24
6.17
7.00
5.3
2.7
%
218.4
197.0
0.37
13
24
(3000991) Gas panel - Venous blood
22
66
4.10
6.81
12.2
6.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13
25
5.92
6.72
3.2
2.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
17
42
4.77
6.71
2.3
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
34
140
3.31
6.57
2.4
1.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
30
116
3.39
6.39
2.5
1.6
—
—
—
0
0
(3024932) HLA-DR beta [Type]
6
0
+∞
6.32
1.3
0.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
25
87
3.61
6.24
2.5
1.6
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
49
263
2.92
5.81
7.9
3.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
17
6.50
5.76
2.8
1.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
34
153
2.98
5.51
4.6
2.8
e6/l
3.6
5.1
0.64
34
134
(36304419) Bacteria [Presence] in Urine
41
208
2.80
5.29
5.8
3.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
42
216
2.79
5.28
5.9
3.1
e6/l
0.2
0.4
0.99
37
154
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
5
0
+∞
5.25
1.6
0.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
9
9
10.95
5.15
6.7
1.9
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
9
9
10.95
5.15
6.7
1.9
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
9
9
10.95
5.15
6.7
1.9
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
31
137
2.94
5.15
4.5
2.5
e6/l
0.9
0.9
0.07
21
79
(3021589) Normoblasts [#/volume] in Blood
55
330
2.75
5.04
29.1
8.9
e9/l
0.0
0.0
1.12
45
257
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
37
183
2.75
4.96
6.6
2.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
18
59
3.57
4.84
13.1
3.2
%
1.3
0.2
—
9
16
(3042936) Bacteria identified in Isolate by Culture
26
108
2.99
4.78
3.6
2.0
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
43
235
2.61
4.66
6.8
3.1
e6/l
38.8
40.9
0.03
38
174
(3026008) Bacteria identified in Urine by Culture
41
221
2.59
4.55
3.8
3.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
43
238
2.56
4.51
8.4
2.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
9
12
8.20
4.47
6.0
1.5
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
8
9
9.62
4.37
1.9
1.9
mg/l
2.7
3.8
—
8
9
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
7
6
12.50
4.35
3.1
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
7
6
12.50
4.35
3.6
2.7
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
59
384
2.59
4.33
25.3
7.0
umol/l
11.5
11.4
0.03
59
365
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
17
58
3.39
4.28
8.4
3.9
mmol/l
1.3
1.5
0.11
12
41
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
28
128
2.73
4.28
5.6
2.6
e6/l
1.5
2.1
0.22
17
70
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
9
13
7.56
4.28
2.9
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
17
59
3.33
4.17
13.4
3.3
%
0.4
0.5
0.11
11
18
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
9
14
7.01
4.09
6.1
1.4
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
7
7
10.71
4.08
7.7
1.4
e9/l
0.2
0.1
—
7
7
(3032080) INR in Blood by Coagulation assay
48
290
2.42
4.06
26.9
7.3
inr
1.2
1.2
0.22
14
76
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
12
34
3.92
3.92
2.4
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
54
349
2.39
3.86
14.0
4.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
8
9.37
3.84
2.0
1.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
41
236
2.37
3.81
6.0
3.2
mmol/l
2.3
2.4
0.97
41
203
(3008757) Leukocyte morphology finding [Identifier] in Blood
8
12
7.20
3.76
19.6
4.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
7
9
8.32
3.63
1.1
1.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
31
161
2.42
3.59
3.8
1.5
g/l
2.1
2.2
0.11
24
89
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
16
60
3.03
3.45
6.2
4.0
ml/min/173m2
51.4
68.2
—
5
30
(3004588) Protein electrophoresis panel - Serum or Plasma
13
43
3.37
3.41
5.9
3.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
43
263
2.23
3.37
1.7
2.0
pmol/l
86.2
92.1
0.35
26
128
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
12
38
3.49
3.35
10.3
7.6
%
0.7
0.7
0.18
12
38
(3018095) Leukocytes [#/volume] in Urine
44
273
2.21
3.31
8.4
3.5
e6/l
67.5
67.4
0.00
38
185
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
6
7
9.08
3.31
2.3
1.7
g/l
0.8
0.9
—
6
7
(40760892) CBC W Ordered Manual Differential panel - Blood
30
159
2.34
3.28
16.3
5.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
8
15
5.74
3.27
2.9
1.7
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
12
39
3.40
3.23
10.3
7.4
%
1.4
1.6
0.16
12
39
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
10
29
3.76
3.15
4.4
3.0
u/ml
0.3
0.4
—
5
20
(3001122) Ferritin [Mass/volume] in Serum or Plasma
45
287
2.15
3.11
6.9
2.5
ug/l
327.9
105.7
3.56
45
264
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
17
71
2.72
3.02
5.3
4.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
5
10.48
3.01
1.2
1.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
5
10.48
3.01
1.2
1.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
14
53
2.95
2.96
5.6
3.7
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
7
13
5.74
2.93
9.1
5.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
13
5.74
2.93
2.7
1.7
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
7
14
5.33
2.78
8.0
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
34
204
2.08
2.68
6.1
4.0
mg/mmol
28.4
10.2
0.78
27
125
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
20
4.29
2.63
1.0
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
8
20
4.29
2.63
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
8
20
4.29
2.63
1.3
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
11
39
3.08
2.58
2.4
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
32
190
2.07
2.58
5.7
3.3
mg/l
1628.6
54.0
0.50
27
114
(3000494) Fungus identified in Specimen by Culture
18
84
2.43
2.56
3.0
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
51
360
1.98
2.51
6.8
3.3
estimate
0.0
0.0
—
9
65
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
72
578
2.29
2.46
26.9
7.5
u/l
92.3
84.4
0.50
72
539
(3021901) Oxygen saturation in Capillary blood
6
12
5.27
2.44
4.2
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
7
17
4.37
2.41
4.6
2.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
8
6.54
2.40
2.0
2.3
pg
34.4
31.6
—
5
8
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
8
6.54
2.40
1.4
1.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
29
170
2.05
2.39
5.5
3.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
6
13
4.86
2.31
2.5
1.3
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
6
13
4.86
2.31
1.2
1.2
mg/l
13.0
11.6
—
6
13
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
7
18
4.13
2.30
8.4
1.2
e6/l
64.3
374.5
—
7
13
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
7
18
4.13
2.30
8.4
1.1
e6/l
55.0
2.3
—
7
13
(3021601) Nitrite [Presence] in Urine by Test strip
50
358
1.91
2.29
8.6
4.5
estimate
0.0
0.0
—
8
69
(40768441) Liver Pathology biopsy report
5
9
5.81
2.24
2.6
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
14
4.51
2.19
1.7
1.2
—
—
—
0
0
(3015736) pH of Urine
42
288
1.87
2.17
4.9
3.0
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
10
5.22
2.10
4.2
1.9
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
10
5.22
2.10
1.2
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
10
5.22
2.10
4.2
1.9
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
10
5.22
2.10
4.2
1.9
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
10
5.22
2.10
4.2
1.9
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
6
15
4.21
2.07
4.3
1.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
30
187
1.91
2.05
8.6
3.7
estimate
0.0
0.0
—
7
67
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
11
4.74
1.97
1.2
1.0
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
11
4.74
1.97
4.2
1.8
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
11
4.74
1.97
4.2
1.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
32
209
1.83
1.88
2.0
1.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
6
17
3.70
1.87
1.7
1.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
6
17
3.70
1.87
7.5
3.7
%
54.8
57.1
—
6
17
(3030905) Polymorphonuclear cells [#/volume] in Blood
6
17
3.70
1.87
6.2
3.2
e9/l
3.5
4.7
—
6
17
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
9
35
2.74
1.86
5.9
7.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
7
23
3.21
1.84
3.7
3.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
48
357
1.75
1.80
7.1
3.2
estimate
0.0
0.0
—
9
71
(3022313) Gas panel - Capillary blood
11
49
2.42
1.71
8.4
3.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
40
288
1.71
1.65
2.9
1.8
—
—
—
0
0
(3020891) Body temperature
7
26
2.83
1.61
14.4
7.0
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
7
28
2.62
1.48
3.9
3.4
u/ml
17.9
325.2
—
7
22
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
37
269
1.64
1.43
7.6
3.5
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
5
17
3.05
1.38
1.2
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
10
48
2.22
1.33
21.9
5.3
mmol/l
1.2
1.2
—
10
42
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
25
2.50
1.26
1.3
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
59
492
1.59
1.23
6.1
3.6
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
5
20
2.59
1.16
3.2
1.4
nmol/l
59.4
37.8
—
5
20
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
7
30
2.44
1.15
10.4
2.1
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
5
21
2.46
1.10
1.0
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
16
238
0.60
1.02
2.2
2.8
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
9
49
1.93
1.02
1.8
2.8
ng/l
296.9
276.3
—
9
44
(3022621) pH of Urine by Test strip
9
50
1.89
1.00
8.0
2.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
30
0.00
0.99
0.0
1.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
9
51
1.85
0.98
5.9
5.2
—
—
—
0
0
(3002256) Pathology report gross observation
14
86
1.75
0.98
1.8
1.2
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
10
55
1.92
0.96
11.2
4.9
mmol/l
24.6
25.3
—
10
55
(42529406) Shigella sp [Presence] in Stool by Culture
6
28
2.22
0.93
2.3
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
28
2.22
0.93
4.3
2.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
6
28
2.22
0.93
2.3
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
6
28
2.22
0.93
2.3
1.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
6
33
1.88
0.80
10.7
2.5
e6/l
0.1
0.0
—
6
33
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
0
24
0.00
0.80
0.0
1.2
—
2.2
—
0
13
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
0
24
0.00
0.80
0.0
1.5
—
3.0
—
0
14
(3000492) Spirometry study
10
60
1.75
0.75
2.0
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
7
40
1.81
0.73
1.1
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
11
69
1.68
0.72
1.0
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
5
26
1.98
0.72
1.2
2.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
58
517
1.35
0.62
8.7
4.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
5
30
1.71
0.62
3.4
4.1
g/l
0.5
0.2
—
5
13
(3013512) EKG study
14
192
0.68
0.60
6.4
4.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
53
474
1.29
0.51
3.0
3.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
11
76
1.51
0.51
1.3
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
73
769
0.72
0.48
40.9
13.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
24
195
1.32
0.47
7.7
3.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
67
623
1.31
0.45
60.0
15.8
%
14.5
13.6
2.90
67
616
(40768443) Skin Pathology biopsy report
5
33
1.54
0.42
1.0
1.2
—
—
—
0
0
(3019225) pH of Specimen
9
68
1.36
0.39
11.2
4.8
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
6
43
1.42
0.36
2.3
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
65
687
0.80
0.35
5.9
4.4
mmol/l
5.9
5.9
0.12
59
632
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
31
275
1.20
0.28
7.7
3.6
ng/l
37.2
41.9
0.11
26
188
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
77
743
1.27
0.26
58.5
13.6
mg/l
27.2
22.8
0.84
72
561
(3019832) Treponema pallidum Ab [Presence] in Serum
9
76
1.20
0.25
2.9
1.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
7
91
0.75
0.24
1.7
2.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5
39
1.30
0.23
1.8
1.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
17
145
1.21
0.22
1.5
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
11
89
1.27
0.22
16.8
6.9
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
1.5
—
0
5
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
5.4
—
114.5
—
0
10
(40768800) Prostate Pathology biopsy report
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
0.6
—
0
5
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.5
—
21.0
—
0
10
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
7
57
1.25
0.19
4.3
4.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
5
69
0.71
0.17
1.2
2.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
51
486
1.12
0.15
6.8
3.2
u/l
53.9
49.2
0.22
51
455
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
76
777
0.85
0.14
34.4
10.4
u/l
27.3
26.2
0.24
76
756
(3009542) Hematocrit [Volume Fraction] of Blood
70
681
1.13
0.13
45.2
13.8
%
34.2
40.4
3.83
55
511
(3020564) Creatinine [Moles/volume] in Serum or Plasma
76
776
0.86
0.12
56.8
15.6
umol/l
111.4
75.4
1.84
76
776
(4010399)
6
53
1.14
0.09
2.3
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
10
113
0.87
0.09
1.1
1.2
u/ml
5.2
7.9
—
5
42
(21494755) Public health laboratory ask at order entry panel
6
57
1.06
0.09
1.2
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
7
83
0.83
0.07
1.6
1.8
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
9
88
1.03
0.07
1.1
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
17
182
0.92
0.06
2.6
4.0
%
34.5
22.5
—
8
93
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
10
106
0.94
0.01
1.8
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
11
116
0.94
0.01
1.0
1.3
iu/ml
17.5
38.3
—
5
44
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
68
674
1.04
0.00
4.9
4.6
mu/l
2.0
1.9
0.45
63
618
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
65
652
0.99
0.00
42.9
12.8
ml/min/173m2
70.4
81.7
2.18
58
508
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(4281824)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
0
5
0.00
0.00
0.0
1.4
—
5.4
—
0
5
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
8
0.00
0.00
0.0
1.3
—
13.3
—
0
8
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
6
62
0.97
0.00
1.0
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(4027681)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.5
—
43.3
—
0
6
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(4146454)
0
8
0.00
0.00
0.0
3.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
4.0
—
2.2
—
0
9
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
5
54
0.92
0.00
2.4
2.3
—
6.2
—
0
5
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_OTHER_LEUKAEMIA_SPECIFIED – Other leukaemias of specified cell type
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).